Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)
Clinical trial NCT00844805 · COMPLETED
Trial details
- NCT number
- NCT00844805
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.